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Describe the screening and recruitment process of a randomised trial and evaluate 
associations with knee pain and function three months after total knee replacement (TKR). 
Methods 
To screen for a multi-centre trial, 5036 patients were sent an Oxford Knee Score (OKS) 
questionnaire 10 weeks post-TKR. Patients who reported pain in their replaced knee (≤14 on 
OKS pain component), completed a second OKS 12 weeks post-TKR. Those still 
experiencing pain 12 weeks post-TKR completed a detailed questionnaire 13 weeks post-
TKR. These data were used to characterise pain in a cross-sectional analysis. Multivariable 
regression was performed, identifying factors associated with pain and function at 13 weeks 
post-TKR.  
Results  
We received OKS questionnaires from 3058/5063 (60%) TKR patients, 907/3058 (30%) 
reported pain in their replaced knee 10-weeks post-operatively. By 12-weeks, 179/553 (32%) 
patients reported improved pain (OKS>14). At 13-weeks, 192/363 (53%) who completed a 
detailed questionnaire reported neuropathic pain, 94/362 (26%) reported depression 
symptoms and 95/363 (26%) anxiety symptoms. More severe pain at 13-weeks post-




operatively was associated with poorer general health, poorer physical health, more pain 
worry and lower satisfaction with surgery outcome. More severe functional limitation was 
associated with higher levels of depression, more pain worry, lower satisfaction with surgery 
outcome and higher pain acceptance. 
Conclusions 
Screening after TKR identified people with pain. We identified several potential targets 
(physical and mental health outcomes, acceptance of pain and quality of life) for tailored 
intervention to improve outcomes for patients. Trials of multidisciplinary interventions are 
now needed.  
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Significance and innovations  
 Good uptake to early postoperative screening of pain and function after TKR 
 Half of patients with pain at three months after TKR report neuropathic pain 
symptoms  
 A quarter of patients with pain at three months after TKR report depression and/or 
anxiety  
 Multiple factors such as quality of life, physical and mental health outcomes and 
acceptance of pain are associated with more severe pain and function after TKR, 
highlighting the need for multidisciplinary interventions  
 




Primary total knee replacement (TKR) is a common operation, with over 100,000 operations 
performed in the UK’s National Health Service (NHS) in 2019 (1, 2). The main indications 
for TKR are chronic pain and functional limitations, predominately related to osteoarthritis. 
Although the operation is successful for many, 10-34% of patients experience ongoing pain 
in the months and years after surgery (3). Despite its prevalence, knowledge about the onset 
and postoperative trajectory of chronic pain after TKR is not well understood (4). The 
evidence base for treatment and management is sparse (5, 6), and referrals for assessment and 
care are inconsistent (7, 8). As yet there is no pre-operative model that can accurately predict 
who will have chronic pain after surgery (5, 9). People with chronic pain after TKR can feel 
abandoned by healthcare services and struggle to understand ongoing pain (10). 
The improvement trajectory following TKR is variable: however, most pain relief occurs 
within the first three months postoperatively (11). Persistent pain at three months could be 
due to slower recovery or an early indication of longer-term chronic pain. Chronic pain is 
difficult to treat once established (12) and the identification and characterisation of pain early 
in the recovery trajectory could facilitate the delivery of targeted interventions to support 
recovery and improve longer-term pain outcomes. Hence, there is potential for early 
identification of these patients to explore whether intervention is warranted. 
Previous studies have described pain after TKR (3, 13-17), but these studies have 
methodological shortcomings that have contributed to the poor quantification and 
characterisation of pain after TKR, These include: use of surgeon-administered tools to assess 
pain, limited assessment of the multidimensional nature of pain, variable definitions of pain 
resulting in different prevalence estimates, and single centre studies, limiting generalisability 
(3, 16, 18). A robust method of identifying patients with pain after TKR using the OKS pain 
component has been developed (19). Using data from a national population-based cohort  
across England, patients with a postoperative score of ≤14 on the OKS pain component were 




identified as having pain likely to negatively impact on health-related quality of life (19). 
Applying this method for identification of patients with pain in the first three months post-
operatively allows the early investigation of pain characteristics. The aim here is to describe 
our screening procedures to identify people with postoperative pain and to identify 
associations with pain and function amongst patients with pain in the first three months after 
primary TKR.  
 
PATIENTS AND METHODS 
Design  
The data analysed in this article are from the Support and Treatment After joint Replacement  
(STAR) trial, a multicentre randomised trial evaluating the effectiveness of a care pathway 
for patients with chronic pain at three months after TKR (20). Screening data included in 
these analyses were collected before randomisation and are analysed as observational data. 
Study methods relevant to these analyses are described and reported following STROBE 
guidance (Supplementary Table 1).  
Patient and public involvement (PPI) 
This research was conducted in collaboration with the ‘Patient Experience Partnership in 
Research (PEP-R) STAR group, a specialised group comprising five patients with experience 
of chronic pain after TKR. Through regular group meetings, patient representatives 
contributed to project design and management.  
Participants 
Between September 2016 and May 2019, eligible patients were recruited into the STAR trial 
from eight NHS orthopaedic centres in Bristol, Cardiff, Exeter, Mansfield, Oswestry, 




Wrightington, Leicester and Birmingham. Inclusion criteria included adults who received a 
primary TKR for osteoarthritis and reported pain in their replaced knee 12 weeks post-
operatively. Exclusion criteria included lack of capacity to provide informed consent, 
previous study participation for the contralateral knee, or participation in another project that 
interfered with STAR. STAR complied with the Declaration of Helsinki and was approved by 
the South West – Central Bristol Research Ethics Committee (16/SW/0154) and the Health 
Research Authority. All participants provided written, informed consent, in two stages: first 
for the screening study only, comprising OKS measurements at 10 and 12 weeks after TKR 
and, second for the main STAR trial, comprising a detailed baseline questionnaire at 13 
weeks after TKR. Identification of patients with pain after TKR began at 10 weeks post-
operatively to ensure timely identification of those with pain that persisted at three months 
post-operatively. We report our findings of screening procedures and the cross-sectional 
analysis of associations with pain and function at 13 weeks after TKR surgery.  
Initial postal screening to identify patients with pain 10 weeks after TKR 
Patients who received a primary TKR for osteoarthritis eight weeks previously were sent a 
study information leaflet, consent form and short initial screening questionnaire, including 
the OKS (21) and sociodemographic questions. Non-responders received a single reminder. 
The OKS is a joint-specific measure of pain and function consisting of 12 items with 5 
ordinal response options for each (21). There is evidence of validity and reliability, with the 
OKS being reported as the best performing site-specific patient reported outcome measure in 
a psychometric review of 32 measures used in hip and knee replacement surgery (22). It has 
an overall score ranging from 0-48 (worst to best). Two subscales can be calculated: a 5-item 
OKS function component (raw score of 0-20) and a 7-item OKS pain component (raw score 
of 0-28). Patients with a score of 0-14 on the raw OKS pain component were considered as 
having pain that was likely to negatively impact on health-related quality of life (19). It is 




recommended that the component scores are standardised to a 0-100 scale (worst to best) for 
analysis (23). 
Second telephone screening to confirm ongoing pain 12 weeks after TKR 
All responding patients reporting an OKS pain score ≤14 at 10 weeks were contacted by 
telephone at 12 weeks and invited to complete a second screening questionnaire repeating the 
OKS to confirm their pain status. Those still reporting clinically meaningful pain (defined as 
an OKS pain score ≤14) at 12 weeks were eligible for invitation to enter the trial.  
Detailed study questionnaire at 13 weeks after TKR for patients with pain  
Participants who gave their consent to the trial completed a third OKS as part of a more 
detailed study questionnaire prior to randomisation. If questionnaires were not returned 
within one week, the participant was offered support on the telephone with a researcher.  
The outcomes assessed in the questionnaire administered at 13 weeks post-operatively 
reflected the eight domains of the core outcome set for chronic pain after TKR (24). Pain 
severity and pain interference were assessed using the Brief Pain Inventory (BPI) (subscale 
scores from 0-10; best to worst) (25). Knee pain and function were measured using the OKS. 
Pain with neuropathic features was assessed using two questionnaires. First, the PainDetect 
(26), which can be analysed as a continuous score  (-1 to 38, with a higher score indicating 
greater likelihood of neuropathic pain) or categorised into nociceptive pain (-1 to 12), 
possible neuropathic pain component (13-18) or probable neuropathic pain component (19-
38). Secondly, the Dolour Neuropathic scale (DN-4) (27), with scores ranging from 0-7 (best 
to worst) and a score of ≥3 indicating neuropathic pain characteristics. Single questions 
evaluated the frequency of pain in the past 24 hours and four weeks and how this compared 
to pre-operative pain. General health was measured using the SF-12 (28), comprising a 
Physical Component Score (PCS) and a Mental Component Score (MCS) (0-100; worst to 




best). Health-related quality of life was assessed by the EQ-5D-5L (29) (-0.594 to 1 where 1 
indicates ‘perfect health’ and 0 indicates ‘dead’) and capability by the ICECAP-A (30) (-
0.001 to 1, worst to best). Depression and anxiety were assessed using the Hospital Anxiety 
and Depression Scale (HADS) (31), with subscale scores (HADS-A; HADS-D) ranging from 
0-21 (best to worst) and categorised into unlikely symptoms of depression/anxiety (0-7), 
possible depression/anxiety (8-10) and probable depression/anxiety (11-21). Worry about 
pain was assessed with the Pain Catastrophizing Scale (PCS; scored 0-52; best to worse) (32) 
which consists of three subscales labelled rumination (scored 0-16), magnification (0-12) and 
helplessness (0-24). The Possible Solutions to Pain Questionnaire (PaSol) (33) was also 
completed and the four subscales analysed: solving pain (scored 0-24; worst to best), 
meaningfulness of life despite pain (0-30), acceptance of the insolubility of pain (0-18), and 
belief in solutions (0-12). Patient satisfaction with the outcome of surgery was measured by 
the Self-Administered Patient Satisfaction Scale (34), a 4-item arthroplasty-specific score 
(25-100; worst to best). Painful body regions were indicated on a body diagram, and 
widespread pain was defined as pain in at least two sections of each two contralateral limbs 
and in the axial skeleton (35). Sociodemographic questions included age, gender, marital and 




As well as response rates, distributions of screening OKS scores were assessed at each phase 
using histograms and summary statistics such as means (SD). Regression analyses were 
performed on the OKS pain and function subscores as the outcome variables to explore the 
associations with age and gender. Results are presented using regression coefficients, 95% 




confidence intervals and p-values. The relationship between the OKS subscales were assessed 
using scatter plots, replicated stratified by age group (<60; 60-70; 71-80; >80) and gender. 
Study questionnaire analyses  
Summary statistics for sociodemographic data and patient-reported outcomes were presented 
using means (SD)/medians (IQR)/counts (%). Distributions of the OKS scales were presented 
as histograms to assess normality. Correlation coefficients between pain outcomes were 
evaluated. Linear regression was used to evaluate the factors independently associated with 
the OKS pain and function scores. Staged regression was then used to select variables 
systematically for the linear regression model ((36) is an example of this approach). 
Associations were explored between OKS pain and the following groups of factors: 
sociodemographic variables; general health; mental health measures. Each group of variables 
was first explored separately in multivariable regression models, with (iterative) exclusion of 
variables without strong associations with OKS pain when adjusted for other variables in the 
model. The process was then extended to consider all groups together, resulting in a ‘final’ 
regression model containing only variables that were strongly associated with OKS pain, 
adjusted for other variables. This process was repeated for OKS function exploring 
associations with sociodemographic variables and mental health outcomes. In all analyses, 
the standardised OKS pain and function scores (0-100) were used (23). 
Data completeness is reported in the Tables and Figures. For the OKS component scores, the 
mean of other items on the subscale was used to impute a missing item if only one item was 
missing. If more than one item was missing, a score was not calculated (37). The approach to 
missing data for other validated questionnaires followed guidance recommended by the 
questionnaire developers; further details are in the STAR trial statistical analysis plan (38).  
Sample size 




The sample size for the STAR trial was based on detecting a minimal clinically important 
difference between trial arms in the BPI subscales at 12 months after randomisation (20). We 
did not undertake a separate power calculation for the analyses presented here as our 
intention was to investigate characteristics of the study population collected prior to 
randomisation; rather the levels of achieved precision are indicated through the relevant 
confidence intervals.  
 
RESULTS 
Recruitment, screening and participant flow 
An overview of participant flow through the study is provided in Figure 1. Screening 
questionnaires to identify patients with pain after TKR were posted to 5,036 patients who had 
a TKR at one of eight orthopaedic centres. Completed screening questionnaires were returned 
by 3,058 patients (61%) at a mean (SD) of 10 (2) weeks post-operatively. Of these, 907 
(30%) patients reported pain in their replaced knee at 10 weeks, of whom 553 (61%) 
completed a second telephone OKS to confirm pain status at 12 weeks (SD = 2 weeks). The 
mean (SD) age of the 553 patients who completed a telephone questionnaire was 67.7 (8.6) 
years with 56% being female. Those who did not complete a telephone questionnaire at 12 
weeks (n=354) were slightly older, with a mean (SD) age of 69.4 (10.4) years and 62% were 
female. Patients who completed the 12 week telephone-administered OKS had a slightly 
higher mean OKS (18.2; SD = 5.4) than those who did not complete a telephone OKS (17.2; 
SD = 5.7) indicating less pain and better function in responders compared with non-
responders at 12 weeks. 363/553 (66%) patients completed a detailed questionnaire at 13 
weeks (SD 2 weeks).  




Sociodemographic characteristics of responders and non-responders to the screening 
questionnaire at 10 weeks are provided in Table 1(A). Mean age was comparable (70 years), 
although females were slightly less likely to respond than males (55% vs. 62%). The OKS 
overall and component scores are in Table 1(A) and Supplementary Figures 1 and 2. Overall, 
907/3,058 patients (30%) reported clinically meaningful pain in their replaced knee at 10 
weeks (OKS pain component ≤14).  
Scatter plots of the OKS component scores demonstrated a linear relationship between pain 
and function, with similar patterns when stratified by gender and age (Supplementary Figures 
3-5). Younger age and female gender were associated with worse knee pain severity and 
functional limitations at 10 weeks (Table 2).  
Of the 533/907 patients to complete the OKS by telephone, 179 (32%) reported an 
improvement in their pain (>14 OKS) but 374 (68%) remained in pain. Summary statistics of 
age, gender and week 10 OKS scores for those who did and did not respond at week 12 are 
presented in Table 1(B). Responders were slightly younger than non-responders at 12 weeks 
with a lower proportion of females responding (Table 1(B)). Responders at 12 weeks had 
slightly higher 10 week OKS scores compared with those who did not respond at 12 weeks. 
Characterisation of people reporting pain at 13 weeks post-TKR 
Sociodemographic characteristics and patient-reported outcomes for the 363/374 (97%) 
participants who completed a detailed questionnaire at 13 weeks are in Table 3.  These 
participants had a mean age of 67 years (SD 9) and 60% were female. Neuropathic pain 
characteristics were common, with half (53%) of participants having a PainDETECT score 
that indicated likely neuropathic pain (score > 19) and three-quarters (74%) of patients 
having neuropathic pain characteristics according to the DN-4 (a score of ≥3). 47% of 
patients had both likely neuropathic pain according to PainDetect and neuropathic pain 




according to the DN-4. Poor mental health was also common, with patients having HADS 
scores indicative of either probable depression (26%) or anxiety (26%); of these 60/362 
(17%) reported symptoms of both depression and anxiety. Over the previous four weeks, 
96% of patients had experienced pain frequently, defined as pain being present ‘often’, ‘most 
of the time’ or ‘all the time’. Almost half (44%) reported their pain as ‘a bit worse’ or ‘much 
worse’ than their pre-operative pain. Despite still being in pain at 12 weeks, most (74%) were 
satisfied with their overall outcome from TKR and 55% were satisfied with their pain relief, 
although satisfaction rates with ability to do activities of daily living and leisure activities 
were lower (39% and 38%, respectively).  
Regression analysis 
Results of the linear regression model with the OKS pain component as the outcome are 
displayed in Table 4. In this cross-sectional analysis, having more severe knee pain at 13 
weeks was associated with lower general health measured by the EQ 5D 5L utility score, 
lower physical health measured by the SF-12, higher pain worry (PCS), lower satisfaction 
with the outcome of surgery.  
From the linear regression model with the OKS function component as the outcome (Table 
5), in patients with pain at 13 weeks postoperatively, more severe functional limitation was 
associated with higher levels of depression, higher pain catastrophizing, lower satisfaction 
with the outcome of surgery and higher levels of acceptance of the insolubility of pain.  
  
DISCUSSION 
This study examined characteristics of people reporting pain 10 to 13 weeks after TKR. We 
used the validated OKS pain component threshold to identify patients with pain in the first 
three months after TKR. Using this standardised pain definition, 30% of patients reported 




pain in their replaced knee 10 weeks after surgery. Of the 553 patients who completed a 
second OKS by telephone (12 weeks after TKR), 30% reported an improvement in their OKS 
pain score from the 10 week measurement. However, for the majority (70%), the pain was 
still present at three months. Applying the OKS pain threshold allowed an in-depth evaluation 
of the characteristics of patients with pain at three months after TKR. We found that over half 
of patients reported pain with neuropathic characteristics and a quarter of patients reported 
probable depression or anxiety, with 17% reporting both depression and anxiety. Despite still 
having problems with pain, three-quarters of these patients were satisfied with their TKR 
outcome. Patients with more severe knee pain at three months were likely to have poorer 
general health, poorer physical health, higher pain worry (measured as pain catastrophizing) 
and lower satisfaction with the outcome of surgery. Patients with greater functional 
limitations were more likely to have higher levels of depression, higher pain worry, lower 
satisfaction with the outcome of surgery, and higher levels of acceptance of the pain’s 
insolubility.  
Previously, the lack of a robust approach to screening has been a barrier to the 
implementation of new services to improve care for patients with pain after TKR (7). Our 
study demonstrated that early screening using the OKS definition of chronic pain as a 
standardised approach to identify patients with pain is achievable. In our large multicentre 
trial, one third met our definition of pain at 10 weeks; this is not unexpected as TKR has a 
long recovery period and individual patients’ recovery trajectories vary (11). A third of 
patients with pain at 10 weeks had improved by 12 weeks, demonstrating that patients can 
experience rapid recovery during this early post-operative period. However, 70% of 
responding patients with pain at 10 weeks still had pain at 12 weeks, and for some, this pain 
is likely to persist in the longer-term. Early screening to identify patients with pain at three 




months could facilitate targeted care delivery to prevent the transition of acute pain to chronic 
pain, for example through transitional pain clinics (39).  
The prevalence of neuropathic pain after TKR and other types of surgery differs in the 
literature, likely due to variation in definition and measurement (40). This warrants further 
research and suggests a potential role for routine screening and treatment of neuropathic pain 
after TKR. A systematic review has identified inadequate response to pharmacotherapy for 
neuropathic pain, that relates to modest efficacy, high placebo rates and poor phenotyping 
(41).  Further work could examine the development of targeted interventions including non-
pharmacological treatments. For example, the National Institute for Health and Care 
Excellence (NICE) currently recommends trials comparing the effectiveness of combination 
therapy versus monotherapy for neuropathic pain (42). Another potential target for 
intervention is depression and anxiety, reported by a quarter of participants. Given the known 
association between mental health and chronic pain (43), concurrent treatment of both 
conditions may improve outcomes for patients. An interesting finding was, despite ongoing 
pain, satisfaction with treatment was high. This may have been in part influenced by the 
relatively early timepoint of assessment post-surgery and an acceptance that initial 
postoperative pain is part of the recovery trajectory. Satisfaction is a complex construct that 
can be influenced by a wide array of interrelated factors (44). The degree of dissatisfaction 
experienced by patients with chronic pain after TKR has been associated with various factors 
including instability in the coronal plane, stiffness and negative social support (17). Further 
research would help to further understand the factors that influence patients’ satisfaction with 
their outcome.  
Our analysis also identified factors that were associated with more severe pain and functional 
limitations at three months. These associations are consistent with previous studies of pain 
conditions (44-46) and present potential areas for intervention to improve patient outcomes. 




Any such intervention should be multidisciplinary to address the varied nature of factors 
associated with pain. The association of more severe functional limitations with higher levels 
of pain acceptance of the insolubility of pain over and above general measures of mental 
health is highly unusual and deserve further attention. It might be artifactual (floor effect), as 
27% of the sample recorded ‘not applicable’ to the item ‘I can accept that there is no solution 
for my pain’.  Many patients found the idea of accepting the lack of a solution as simply not 
relevant to their early post-operative phase. The association could be explained by some 
patients entertaining the idea of accepting the insolubility of pain because of severity of 
symptoms. Speculatively, it could also demonstrate a fatalistic coping strategy in which one 
expects pain after surgery. This coping style could be negative, acting as a barrier to engaging 
with treatment seeking for pain, or could be positive, acting as a means to disengage from 
unachievable goals (47).  
There are several factors limiting the interpretation of the results from this study. First, the 
response rate of 61% to the initial postal screening questionnaire at 10 weeks, although 
comparable to other surveys of orthopaedic populations (17, 48), may have introduced a 
responder bias (49). Of note, females were slightly less likely to respond to the screening 
questionnaire and female gender was associated with more severe pain at 10 weeks; this may 
underestimate pain prevalence. Second, our screening of patients with pain after TKR began 
at 10 weeks post-operatively, sooner than the internationally accepted three month definition 
of chronic post-surgical pain (50). This approach was necessary to ensure the timely 
identification of patients with post-operative pain at three months. Treatment of pain becomes 
more difficult once pain is established and becomes chronic. Our study demonstrates that 
identification of patients with pain early in the recovery trajectory is feasible to undertake 
(12). Third, the data are cross-sectional so the direction of effects cannot be determined. 
Fourth, our study sample is limited to those with pain three months after TKR, which limits 




the generalisability of our results. When interpreting the baseline factors associated with pain 
and function, we cannot know if these associations are unique to those with pain three months 
after TKR. This is further limited by the lack of preoperative data on our patient cohort; this 
was not feasible although would allow further examination of those at higher risk of post-
TKR pain. Finally, the measurement tools limit interpretation; although the PainDetect and 
DN4 are widely used self-report screening tools for pain with neuropathic characteristics, a 
detailed clinical examination is recommended to confirm diagnosis (51). 
In conclusion, large-scale early screening after TKR identified ongoing pain in a relatively 
high proportion of people, who may benefit from tailored intervention to prevent chronicity. 
Our study found a high prevalence of pain with neuropathic characteristics and identified 
several potential intervention targets to improve outcomes for patients with pain at three 
months post-TKR. Research is needed to build on our findings and evaluate multidisciplinary 
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Tables and Figures  
Table 1: Characteristics of responders and non-responders to screening questionnaire 
at 10 and 12 weeks post-TKR   
(A)  Screening questionnaire at 10 weeks post-TKR   Responders  Non-responders  
N (%) 3058 (61%)  1977 (39%)  
Mean age (SD), years 69.7 (8.8) 69.9 (9.8) 
% females  54.5% 62.2% 
Mean (SD) OKS total score (0-48; worst to best) 29.3 (9.6) - 
Mean (SD) OKS pain component (0-100; worst to best) 62.3 (21.2) - 
Mean (SD) OKS function component (0-100; worst to best) 59.4 (20.8) - 
(B)  Telephone-administered screening questionnaire 
at 12 weeks post-TKR; Eligible at 10 weeks N=907 
Responders at 
12 weeks  
Non-responders 
at 12 weeks  
N (%) 553 (61%)  354 (39%)  
Mean (SD) age  67.7 (8.6) 69.4 (10.4) 
% females  56.2% 62.0% 
Mean (SD) OKS total score at 10 weeks post-op 18.2 (5.4) 17.2 (5.7) 
Mean (SD) OKS pain component at 10 weeks post-op 36.6 (11.3) 35.6 (12.2) 









Table 2: Univariable associations between age, gender, pain and function at 10 weeks 
after TKR  
  OKS pain component OKS function component 
 N Coefficient  
(95% CI) 
p-value Coefficient  
(95% CI) 
p-value 
Age 2,915 0.29 (0.20, 0.37) <0.001 0.09 (0.009, 0.18) 0.030 
Gender (ref = male) 3,042 -3.09 (-4.60, -1.58) <0.001 -7.18 (-8.64, -5.71) <0.001 
 
 




Age  363  
mean (SD)   67.2 (8.7) 
median (IQR), range    67 (61, 73) 40-88 
Sex, N (%)  363  
Female  217 (60) 
Male  146 (40) 
Marital status, N (%)  356  
Single  25 (7) 
Married/Partner  251 (71) 
Divorced /Separated  35 (10) 
Widowed   45 (13) 
Living arrangement, N (%)  356  
Live alone  78 (22) 
With spouse/partner  253 (71) 
With someone else  22 (6) 
Other   3 (1) 
Ethnicity, N (%)  356  
White   335 (94) 
Asian   13 (4) 
Black   5 (1) 
Mixed  1 (<1) 
Other  2 (<1) 




Education level, N (%)  318  
School left <16 years   22 (7) 
School left 16 years  194 (61) 
College  63 (20) 
University   15 (5) 
Other postgraduate   24 (8) 
BPI Scores  363  
BPI Severity, mean (SD)   5.2 (1.7) 
BPI Interference, mean (SD)  6.28 (1.92) 
OKS scores 363  
OKS Total, mean (SD)   18.23 (5.83) 
OKS- Pain*, mean (SD)   36.75 (12.70) 
OKS-Function, mean (SD)  39.70 (14.28) 
Pain Catastrophizing Scale  360  
PCS: total, median (IQR)  18 (9.25, 30.5) 
PCS: Rumination, median (IQR)  8 (4, 12) 
PCS: Magnification, median (IQR)  2 (1, 5) 
PCS: Helplessness, median (IQR)  8 (4, 14) 
Pain Solution (PaSol)   
PaSol: Solving Pain, median (IQR) 362 18 (14, 22) 
PaSol: Meaningful life, median (IQR) 362 22 (18, 26) 
PaSol: Acceptance of the insolubility of pain, median 
(IQR) 
358 8 (5, 11) 
PaSol: Belief in solution, median (IQR) 359 9 (6, 12) 
Patient Satisfaction, mean (SD) 360 62.88 (18.99) 
ICECAP-A, median (IQR) 362 0.78 (0.55, 0.89) 
SF-12   
Physical Score, mean (SD) 363 33.44 (6.51) 
Mental Score, mean (SD) 363 42.19 (11.12) 
EQ-5D-5L, median (IQR) 358 0.53 (0.30, 0.62) 
DN-4  359 3.79 (1.71) 
Score, mean (SD)   
Neuropathic pain characteristics according to DN-4?   
Yes; N(%)  267 (74) 
No; N(%)  92 (26) 
PainDETECT  363 18.19 (6.77) 
Score, mean (SD)   
Neuropathic pain characteristics according to 
PainDETECT? 
  
Unlikely; N (%)  76 (21) 
Ambiguous; N (%)  96 (26) 
Likely; N (%)  191 (53) 
HADS: Anxiety 363  
Normal; N (%)  197 (54) 




Borderline anxiety; N (%)  71 (20) 
Clinical anxiety; N (%)  95 (26) 
HADS: Depression 362  
Normal; N (%)  177 (49) 
Borderline depression; N (%)  91 (25) 
Clinical depression; N (%)  94 (26) 
Pain frequency in past 24 hours 361  
Rarely; N (%)  1 (<1) 
Sometimes; N (%)  40 (11) 
Often; N (%)  98 (27) 
Most of the time; N (%)  164 (45) 
All of the time; N (%)  58 (16) 
Pain frequency in past 4 weeks 362  
Rarely; N (%)  0 (0) 
Sometimes; N (%)  14 (4) 
Often; N (%)  102 (28) 
Most of the time; N (%)  156 (43) 
All of the time; N (%)  90 (25) 
Satisfaction with…   
…Overall results of TKR 359  
Very dissatisfied; N (%)  21 (6) 
Somewhat dissatisfied; N (%)  72 (20) 
Somewhat satisfied; N (%)  154 (43) 
Very satisfied; N (%)  112 (31) 
…Improving pain 359  
Very dissatisfied; N (%)  47 (13) 
Somewhat dissatisfied; N (%)  117 (33) 
Somewhat satisfied; N (%)  139 (39) 
Very satisfied; N (%)  56 (16) 
…Improving ability to do housework or gardening 358  
Very dissatisfied; N (%)  65 (18) 
Somewhat dissatisfied; N (%)  152 (42) 
Somewhat satisfied; N (%)  111 (31) 
Very satisfied; N (%)  30 (8) 
…Improving ability to do leisure activities 359  
Very dissatisfied; N (%)  86 (24) 
Somewhat dissatisfied; N (%)  140 (39) 
Somewhat satisfied; N (%)  106 (30) 
Very satisfied; N (%)  27 (8) 
Comparison of pain to pre-operative pain 362  
Much Better; N (%)  79 (22) 
A bit better; N (%)  70 (19) 
The same; N (%)  54 (15) 
A bit worse; N (%)  77 (21) 




Much worse; N (%)  82 (23) 
Presence of chronic widespread pain (Manchester 
definition) 
363  
Yes; N (%)  16 (4) 













Table 4: Final model from the linear regression for associations with pain at 3 months 
after TKR (n=352) 
 
Variable  Coefficient (95% CI) p-value 
EQ-5D-5L 19.9 (14.1, 25.8) <0.001 
ShortForm-12 (physical) 0.25 (0.09, 0.42) 0.003 
Pain Catastrophising Scale -0.27 (-0.36, -0.17) <0.001 
Satisfaction scale 0.11 (0.05, 0.16) <0.001 
 
Table 5: Final model from the linear regression for associations with function at 3 
months after TKR (n=353)  
 
Variable  Coefficient (95% CI) p-value 
HADS depression -1.18 (-1.55, -0.80) <0.001 
PaSol (acceptance of pain) -0.52 (-0.78, -0.25) <0.001 
Pain Catastrophising Scale -0.24 (-0.36, -0.12) <0.001 












Figure 1: Participant flow  
 
